Based on recent data, Karuna Therapeutics, Inc. (KRTX) shows an Average True Range (ATR) of 3.32 and an Enterprise Value of 12.43B. Its average trading volume over the past 3 months is N/A, indicating liquidity. These fundamental metrics provide insight into KRTX's underlying financial health and market activity.
| ATR | 3.32 |
| Enterprise Value | 12.43B |
| Avg Vol (3 Months) | - |
| Avg Vol (10 Days) | - |
Karuna Therapeutics, Inc. (KRTX) technical indicators as of March 23, 2026: the SMA 20 is 3.27%, SMA 50 at 3.92%, and SMA 200 at 44.47%. The RSI 14 value is 75.4, suggesting its current momentum. These technical analysis signals help assess KRTX's price trends and potential future movements.
| SMA 20 | 3.27% |
| SMA 50 | 3.92% |
| SMA 200 | 44.47% |
| RSI 14 | 75.4 |
Karuna Therapeutics, Inc. (KRTX) stock performance overview as of March 23, 2026: The 52-week high is N/A (currently -0.05% below), and the 52-week low is N/A (currently 108.26% above). Over the past year, KRTX's performance is 64.51%, compared to the S&P 500's 16.54% change.
| 52-Week High | N/A |
| 52-Week High Chg | -0.05% |
| 52-Week Low | N/A |
| 52-Week Low Chg | +108.26% |
| S&P 500 52-Week Chg | 16.54% |
According to market data, Karuna Therapeutics, Inc. (KRTX) stock's recent performance metrics show that over the last month, KRTX is 0.83%, with a Year-to-Date (YTD) performance of 0.91%. Over the past year, the stock has seen a 64.51% change. These figures summarize KRTX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | N/A | N/A | N/A | N/A | N/A | N/A |
| Low | N/A | N/A | N/A | N/A | N/A | N/A |
| Performance | +1.03% | +0.83% | +85.95% | +77.94% | +64.51% | +0.91% |
According to current financial data, KRTX stock's P/E (TTM) ratio is -28.11, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for KRTX, including P/S (19264.95), P/B (9.72), and P/FCF (-32.41), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | KRTX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -28.11 | -1.23 | -5.16 | 32.59 |
| P/S (TTM) | 19264.95 | 3.71 | 464.92 | 5.98 |
| P/B (TTM) | 9.72 | -412.17 | 5.83 | 4.56 |
| P/FCF (TTM) | -32.41 | 70.68 | -188.83 | 31.7 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep